相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Teprotumumab for Dysthyroid Optic Neuropathy: Early Response to Therapy
Connie M. Sears et al.
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (2021)
Teprotumumab for Optic Neuropathy in Thyroid Eye Disease
Dane H. Slentz et al.
JAMA OPHTHALMOLOGY (2021)
DECREASE IN ACROMEGALY-ASSOCIATED THYROID ENLARGEMENT AFTER NORMALIZATION OF IGF-1 LEVELS: A PROSPECTIVE OBSERVATION AND IN VITRO STUDY
Zhiyong Chen et al.
ENDOCRINE PRACTICE (2020)
Insulin-like growth factor-1 enhances the expression of functional TSH receptor in orbital fibroblasts from thyroid-associated ophthalmopathy
Ji Sun Paik et al.
IMMUNOBIOLOGY (2020)
Teprotumumab for the Treatment of Active Thyroid Eye Disease
R. S. Douglas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Nuclear localization and actions of the insulin-like growth factor 1 (IGF-1) system components: Transcriptional regulation and DNA damage response
Elzbieta Poreba et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2020)
New Insights from IGF-IR Stimulating Activity Analyses: Pathological Considerations
Joseph A. M. J. L. Janssen
CELLS (2020)
Is there a role for insulin-like growth factor inhibition in the treatment of COVID-19-related adult respiratory distress syndrome?
Bryan J. Winn
MEDICAL HYPOTHESES (2020)
Insulin-like Growth Factor-I Receptor and Thyroid-Associated Ophthalmopathy
Terry J. Smith et al.
ENDOCRINE REVIEWS (2019)
IGF-IEc Expression Is Associated With Advanced Differentiated Thyroid Cancer
APOSTOLOS K. KARAGIANNIS et al.
ANTICANCER RESEARCH (2019)
Activation of the IGF Axis in Thyroid Cancer: Implications for Tumorigenesis and Treatment
Livia Manzella et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The influence of the lack of insulin receptor substrate 2 (IRS2) on the thyroid gland
Maria Carmen Iglesias-Osma et al.
SCIENTIFIC REPORTS (2019)
Challenges in Orphan Drug Development: Identification of Effective Therapy for Thyroid-Associated Ophthalmopathy
Terry J. Smith
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 59 (2019)
Thyroid Abnormalities in Patients With Extreme Insulin Resistance Syndromes
Yevgeniya S. Kushchayeva et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)
Arrestin-β-1 Physically Scaffolds TSH and IGF1 Receptors to Enable Crosstalk
Christine C. Krieger et al.
ENDOCRINOLOGY (2019)
Modulation of hyaluronan polymer size regulates proliferation of perimysial fibroblasts in thyroid eye disease
Ruiqi Ma et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Thyrocyte-specific deletion of insulin and IGF-1 receptors induces papillary thyroid carcinoma-like lesions through EGFR pathway activation
Sangmi Ock et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Teprotumumab for Thyroid-Associated Ophthalmopathy
Terry J. Smith et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Update of IGF-1 receptor inhibitor (ganitumab, dalotuzumab, cixutumumab, teprotumumab and figitumumab) effects on cancer therapy
Xiao Qu et al.
ONCOTARGET (2017)
Activity of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF1R), in patients (pts) with recurrent or refractory Ewing's sarcoma family of tumors (ESFT): Results of a phase II SARC study.
A. S. Pappo et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Graves' Disease
Terry J. Smith et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
The adverse events profile of anti-IGF-1R monoclonal antibodies in cancer therapy
Honghai Ma et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Phase 1b study of safety, tolerability and efficacy of R1507, a monoclonal antibody to IGF-1R in combination with multiple standard oncology regimens in patients with advanced solid malignancies
Daruka Mahadevan et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2014)
Teprotumumab, an IGF-1R Blocking Monoclonal Antibody Inhibits TSH and IGF-1 Action in Fibrocytes
Hong Chen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Insulin and insulin-like growth factor 1 receptors are required for normal expression of imprinted genes
Jeremie Boucher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Evaluation of thyroid diseases and differentiated thyroid cancer in acromegalic patients
Serkan Dogan et al.
ENDOCRINE (2014)
IGF-1 receptor deficiency in thyrocytes impairs thyroid hormone secretion and completely inhibits TSH-stimulated goiter
Sangmi Ock et al.
FASEB JOURNAL (2013)
Thyroid cancer in patients with acromegaly: a case-control study
Maira Cristina Carvalho dos Santos et al.
PITUITARY (2013)
Thyroid nodules in acromegaly
Amelia Rogozinski et al.
ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA (2012)
A humanized anti-IGF-1R monoclonal antibody (R1507) and/or metformin enhance gemcitabine-induced apoptosis in pancreatic cancer cells
Takako Kawanami et al.
ONCOLOGY REPORTS (2012)
β-Arrestin-biased agonism as the central mechanism of action for insulin-like growth factor 1 receptor-targeting antibodies in Ewing's sarcoma
Huiyuan Zheng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Three Endocrine Neoplasms: An Unusual Combination of Pheochromocytoma, Pituitary Adenoma, and Papillary Thyroid Carcinoma
James C. Sisson et al.
THYROID (2012)
Insulin Receptor Isoforms and Insulin-Like Growth Factor Receptor in Human Follicular Cell Precursors from Papillary Thyroid Cancer and Normal Thyroid
Roberta Malaguarnera et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Randomized Phase II Study of Erlotinib in Combination With Placebo or R1507, a Monoclonal Antibody to Insulin-Like Growth Factor-1 Receptor, for Advanced-Stage Non-Small-Cell Lung Cancer
Suresh S. Ramalingam et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
A Phase I Study of Weekly R1507, A Human Monoclonal Antibody Insulin-like Growth Factor-I Receptor Antagonist, in Patients with Advanced Solid Tumors
Razelle Kurzrock et al.
CLINICAL CANCER RESEARCH (2010)
Neutral Antibodies to the TSH Receptor Are Present in Graves' Disease and Regulate Selective Signaling Cascades
Syed A. Morshed et al.
ENDOCRINOLOGY (2010)
Thyroid Hormone-Mediated Growth and Differentiation of Growth Plate Chondrocytes Involves IGF-1 Modulation of β-Catenin Signaling
Lai Wang et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Thyroid cancer is the most common cancer associated with acromegaly
Bennur Esen Gullu et al.
PITUITARY (2010)
Insulin-Like Growth Factor-I Regulation of Immune Function: A Potential Therapeutic Target in Autoimmune Diseases?
Terry J. Smith
PHARMACOLOGICAL REVIEWS (2010)
Molecular regulation of thyroid gland function
Margaret C. Eggo
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2010)
Differentiation of murine embryonic stern cells to thyrocytes requires insulin and indulin-like growth factor-1
Maria C. Arufe et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Crosstalk Between Epidermal Growth Factor Receptor- and Insulin-Like Growth Factor-1 Receptor Signaling: Implications for Cancer Therapy
J. Veeken et al.
CURRENT CANCER DRUG TARGETS (2009)
Characterization of Thyrotropin Receptor Antibody-Induced Signaling Cascades
Syed A. Morshed et al.
ENDOCRINOLOGY (2009)
The Thyroid-Stimulating Hormone Receptor: Impact of Thyroid-Stimulating Hormone and Thyroid-Stimulating Hormone Receptor Antibodies on Multimerization, Cleavage, and Signaling
Rauf Latif et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2009)
Divergent Frequencies of IGF-I Receptor-Expressing Blood Lymphocytes in Monozygotic Twin Pairs Discordant for Graves' Disease: Evidence for a Phenotypic Signature Ascribable to Nongenetic Factors
Raymond S. Douglas et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Diminished and Irregular Thyrotropin Secretion with Preserved Diurnal Rhythm in Patients with Active Acromegaly
Ferdinand Roelfsema et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Distinct modes of activation of phosphatidylinositol 3-kinase in response to cyclic adenosine 3′, 5′-monophosphate or insulin-like growth factor I play different roles in regulation of cyclin D1 and p27Kip1 in FRTL-5 cells
Toshiaki Fukushima et al.
ENDOCRINOLOGY (2008)
G13-dependent activation of MAPK by thyrotropin
Thomas R. H. Buech et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
B cells from patients with Graves' disease aberrantly express the IGF-1 receptor: Implications for disease pathogenesis
Raymond S. Douglas et al.
JOURNAL OF IMMUNOLOGY (2008)
Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor I receptors: A tale of two antigens implicated in Graves' disease
Shanli Tsui et al.
JOURNAL OF IMMUNOLOGY (2008)
Acromegaly: Re-thinking the cancer risk
Siobhan Loeper et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2008)
Microarray analysis of thyroid stimulating hormone, insulin-like growth factor-1, and insulin-induced gene expression in FRTL-5 thyroid cells
You Jin Lee et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2007)
Upstream stimulatory factor regulates constitutive expression and hormonal suppression of the 90K (mac-2BP) protein
Antonino Grassadonia et al.
ENDOCRINOLOGY (2007)
Phosphatidylinositol 3-kinase/nuclear factor-κB signaling pathway is involved in the regulation of IGF-I on Fas-associated death domain-like interleukin-1-converting enzyme-inhibitory protein expression in cultured FRTL thyroid cells
Meng Ren et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2007)
β-Arrestin and Mdm2 mediate IGF-1 receptor-stimulated ERK activation and cell cycle progression
Leonard Girnita et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Aberrant expression of the insulin-like growth factor-1 receptor by T cells from patients with Graves' disease may carry functional consequences for disease pathogenesis
Raymond S. Douglas et al.
JOURNAL OF IMMUNOLOGY (2007)
Transcriptional regulation of major histocompatibility complex class I gene by insulin and IGF-I in FRTL-5 thyroid cells
C. Giuliani et al.
JOURNAL OF ENDOCRINOLOGY (2006)
Immunoglobulin G from patients with Graves' disease induces interleukin-16 and RANTES expression in cultured human thyrocytes: A putative mechanism for T-cell infiltration of the thyroid in autoimmune disease
AG Gianoukakis et al.
ENDOCRINOLOGY (2006)
β-arrestin is crucial for ubiquitination and down-regulation of the insulin-like growth factor-1 receptor by acting as adaptor for the MDM2 E3 ligase
L Girnita et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Synovial fibroblasts from patients with rheumatoid arthritis, like fibroblasts from Graves' disease, express high levels of IL-16 when treated with Igs against insulin-like growth factor-1 receptor
J Pritchard et al.
JOURNAL OF IMMUNOLOGY (2004)
Immunoglobulins from patients with Graves' disease induce hyaluronan synthesis in their orbital fibroblasts through the self-antigen, insulin-like growth factor-I receptor
TJ Smith et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Immunoglobulin activation of T cell chemoattractant expression in fibroblasts from patients with Graves' disease is mediated through the insulin-like growth factor I receptor pathway
J Pritchard et al.
JOURNAL OF IMMUNOLOGY (2003)
Mannose 6-phosphate receptors: New twists in the tale
P Ghosh et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Igs from patients with Graves' disease induce the expression of T cell chemoattractants in their fibroblasts
J Pritchard et al.
JOURNAL OF IMMUNOLOGY (2002)
Insulin and insulin-like growth factor I receptors: Similarities and differences in signal transduction
J Dupont et al.
HORMONE RESEARCH (2001)
Changes in serum thyroid hormones levels and their mechanisms during long-term growth hormone (GH) replacement therapy in GH deficient children
ES Portes et al.
CLINICAL ENDOCRINOLOGY (2000)
分享论文
